Efficacy of melatonin treatment in a cystic fibrosis mouse model of airway infection
Abstract Approaches to mitigate the severity of infections and of immune responses are still needed for the treatment of cystic fibrosis (CF) even with the success of highly effective modulator therapies. Previous studies identified reduced levels of melatonin in a CF mouse model related to circadia...
Saved in:
Main Authors: | Kristen R. Schaefer, Sara Rogers, Zachary Faber, Thomas J. Kelley |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-025-85948-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Developments in Cystic Fibrosis Airway Inflammation
by: Nades Palaniyar, et al.
Published: (2015-01-01) -
The Involvement of Glycosaminoglycans in Airway Disease Associated with Cystic Fibrosis
by: Emer P. Reeves, et al.
Published: (2011-01-01) -
Free DNA in Cystic Fibrosis Airway Fluids Correlates with Airflow Obstruction
by: Veronica Marcos, et al.
Published: (2015-01-01) -
Treatment of Pseudomonas and Staphylococcus Bronchopulmonary Infection in Patients with Cystic Fibrosis
by: Rashmi Ranjan Das, et al.
Published: (2013-01-01) -
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment
by: Morgan T. Sutton, et al.
Published: (2016-01-01)